Baumgartner M, Behr A, Garbe A, Quatember C, Reutter H, Woelfle J
Children (Basel). 2024; 11(7).
PMID: 39062327
PMC: 11275572.
DOI: 10.3390/children11070877.
Jajosky R, Patel K, Allen J, Zerra P, Chonat S, Ayona D
Blood. 2023; 142(12):1082-1098.
PMID: 37363865
PMC: 10541552.
DOI: 10.1182/blood.2022018591.
Wiedmeier S, Bahr T, Ohls R, Christensen T, Baer V, Ilstrup S
J Perinatol. 2020; 41(4):860-864.
PMID: 32669646
DOI: 10.1038/s41372-020-0736-8.
Gruber D, Richards A, Howie H, Hay A, Lebedev J, Wang X
Blood Adv. 2020; 4(7):1526-1537.
PMID: 32289162
PMC: 7160277.
DOI: 10.1182/bloodadvances.2019001299.
Mener A, Patel S, Arthur C, Stowell S
Transfusion. 2018; 59(1):371-384.
PMID: 30474857
PMC: 7145427.
DOI: 10.1111/trf.14939.
Failure of Anti-D Immunoglobulin Injection to Protect against Rhesus Immunization after Massive Foeto-maternal Haemorrhage. Report of 4 Cases.
de Wit C, Borst-Eilers E
Br Med J. 2010; 1(5585):152-4.
PMID: 20791424
PMC: 1984600.
DOI: 10.1136/bmj.1.5585.152.
Prevention of Rh Immunization Due to Large Volumes of Rh-positive Blood.
Woodrow J, Bowley C, Gilliver B, Strong S
Br Med J. 2010; 1(5585):148-50.
PMID: 20791422
PMC: 1984582.
DOI: 10.1136/bmj.1.5585.148.
The prevention of rh-immunization.
Bowman J
Can Fam Physician. 2010; 23:60-8.
PMID: 20469282
PMC: 2379019.
The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation.
Liumbruno G, DAlessandro A, Rea F, Piccinini V, Catalano L, Calizzani G
Blood Transfus. 2010; 8(1):8-16.
PMID: 20104273
PMC: 2809506.
DOI: 10.2450/2009.0108-09.
A survey of the current use of anti-D immunoprophylaxis and the incidence of haemolytic disease of the newborn in Italy.
Velati C
Blood Transfus. 2009; 5(1):7-14.
PMID: 19204745
PMC: 2535879.
DOI: 10.2450/2007.0018-06.
Forty years of anti-D immunoprophylaxis.
Reali G
Blood Transfus. 2009; 5(1):3-6.
PMID: 19204744
PMC: 2535875.
DOI: 10.2450/2007.0b18-06.
Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn.
Kumpel B
Clin Exp Immunol. 2008; 154(1):1-5.
PMID: 18727626
PMC: 2561090.
DOI: 10.1111/j.1365-2249.2008.03735.x.
PREVENTION OF RH HAEMOLYTIC DISEASE.
Clarke C, Finn R, McConnell R, Woodrow J, Lehane D, Sheppard P
Br Med J. 1964; 1(5390):1110.
PMID: 14113830
PMC: 1814480.
DOI: 10.1136/bmj.1.5390.1110.
Anti-D administration after childbirth for preventing Rhesus alloimmunisation.
Crowther C, Middleton P
Cochrane Database Syst Rev. 2000; (2):CD000021.
PMID: 10796089
PMC: 7061351.
DOI: 10.1002/14651858.CD000021.
The Rhesus story in Northern Ireland.
OSullivan J
Ulster Med J. 1983; 52(2):94-100.
PMID: 6442478
PMC: 2385939.
[Determination of the life span of fetal erythrocytes in adult blood circulation by a new method].
Schneider J, Haefele H
Klin Wochenschr. 1965; 43(12):694-7.
PMID: 5891303
DOI: 10.1007/BF01728710.
Transplacental passage of fetal red cells in abortion; increased incidence after curettage and effect of oxytocic drugs.
Katz J
Br Med J. 1969; 4(5675):84-6.
PMID: 4980842
PMC: 1629506.
DOI: 10.1136/bmj.4.5675.84.
Prevention of Rh hemolytic disease.
Can Med Assoc J. 1967; 97(21):1294-6.
PMID: 4964186
PMC: 1923505.
Clearance of Rh-positive red cells by low concentrations of Rh antibody.
Mollison P, Hughes-Jones N
Immunology. 1967; 12(1):63-73.
PMID: 4959772
PMC: 1409015.
Editorial: Hemolytic disease of the newborn.
Bowman J
Can Med Assoc J. 1974; 111(5):381-2.
PMID: 4412952
PMC: 1947788.
